1. Home
  2. CMRE vs NKTR Comparison

CMRE vs NKTR Comparison

Compare CMRE & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Costamare Inc. $0.0001 par value

CMRE

Costamare Inc. $0.0001 par value

N/A

Current Price

$15.37

Market Cap

1.9B

ML Signal

N/A

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

N/A

Current Price

$71.75

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CMRE
NKTR
Founded
1974
1990
Country
Monaco
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
CMRE
NKTR
Price
$15.37
$71.75
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
$12.00
$146.67
AVG Volume (30 Days)
324.0K
515.9K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
3.10%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$307,711,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.55
N/A
Revenue Growth
N/A
86.00
52 Week Low
$10.84
$27.87
52 Week High
$18.06
$109.00

Technical Indicators

Market Signals
Indicator
CMRE
NKTR
Relative Strength Index (RSI) 54.31 46.71
Support Level $15.16 $70.48
Resistance Level $15.86 $76.49
Average True Range (ATR) 0.44 3.00
MACD 0.06 -0.55
Stochastic Oscillator 73.33 24.10

Price Performance

Historical Comparison
CMRE
NKTR

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and others. The company provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: